Patents by Inventor Sébastian Bonnel

Sébastian Bonnel has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 6663894
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: December 16, 2003
    Assignees: Universite de Paris V Rene-Descartes, Association Francaise Retinitis Pigmentosa
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loic Van Den Berghe, Sebastian Bonnel, Hervé Prats, Jiri Honiger, Martin Neuner-Jehle
  • Patent number: 6500449
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Grant
    Filed: February 1, 2001
    Date of Patent: December 31, 2002
    Assignees: Universite de Paris V Rene-Descartes, Association Francaise Retinitis Pigmentosa
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loïc Van Den Berghe, Sébastian Bonnel, Hervé Prats, Jiri Honiger, Martin Neuner-Jehle
  • Publication number: 20020076396
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Application
    Filed: February 1, 2001
    Publication date: June 20, 2002
    Applicant: Universite de Paris V Rene-Descartes
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loic Van Den Berghe, Sebastian Bonnel, Herve Prats, Jiri Honiger, Martin Neuner-Jehle
  • Publication number: 20020076397
    Abstract: Compositions and methods for reducing ocular diseases by implanting in an eye of a subject a composition comprising encapsulated cells which produce polypeptides, more particularly polypeptides that exhibit neurotrophic and/or anti-angiogenic activity. The encapsulation prevents the entry of host immune cells in the microcapsule while permitting the release of the polypeptide outside of the microcapsule.
    Type: Application
    Filed: February 1, 2001
    Publication date: June 20, 2002
    Applicant: Universite de Paris V Rene-Descartes
    Inventors: Marc Abitbol, Yves Uteza, Maurice Menasche, Carine Bossard, Loic Van Den Berghe, Sebastian Bonnel, Herve Prats, Jiri Honiger, Martin Neuner-Jehle